Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 10
Submit an article Journal homepage
84
Views
11
CrossRef citations to date
0
Altmetric
Letters to the Editor

Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia

J. P. Quinn Department of Haematology, University College London Hospitals, London, UKCorrespondence[email protected]
,
S. Mohamedbhai Department of Haematology, University College London Hospitals, London, UK
,
K. Chipperfield Department of Haematology, University College London Hospitals, London, UK
,
M. Treacy Department of Haematology, Chase Farm Hospital, London, UK
,
S. D'Sa Department of Haematology, University College London Hospitals, London, UK
&
A. C. Nathwani Department of Haematology, University College London Hospitals, London, UK
Pages 1995-1998 | Received 20 May 2008, Accepted 11 Jul 2008, Published online: 01 Jul 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lukáš Smolej. (2012) The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 21:7, pages 1009-1017.
Read now
Alessandra Tedeschi, Eleonora Vismara, Francesca Ricci, Enrica Morra & Marco Montillo. (2010) The spectrum of use of rituximab in chronic lymphocytic leukemia. OncoTargets and Therapy 3, pages 227-246.
Read now
Andrew R. Pettitt. (2008) Glucocorticoid-based combination therapy for chronic lymphotic leukemia: new tricks for an old dog. Leukemia & Lymphoma 49:10, pages 1843-1845.
Read now

Articles from other publishers (8)

Martin Šimkovič, Pavel Vodárek, Monika Motyčková, Dominika Écsiová, Petra Rozsívalová, Heidi Móciková, Pavla Štěpánková, Alice Sýkorová, Kateřina Hrochová, Filip Vrbacký, David Belada, Pavel Žák & Lukáš Smolej. (2020) Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia. European Journal of Clinical Investigation 51:4.
Crossref
Michael Doubek, Yvona Brychtova, Anna Panovska, Ludmila Sebejova, Olga Stehlikova, Jana Chovancova, Jitka Malcikova, Jana Smardova, Karla Plevova, Pavlina Volfova, Martin Trbusek, Marek Mraz, Denisa Bakesova, Jakub Trizuljak, Marketa Hadrabova, Petra Obrtlikova, Josef Karban, Lukas Smolej, Alexandra Oltova, Eva Jelinkova, Sarka Pospisilova & Jiri Mayer. (2015) Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study. American Journal of Hematology 90:5, pages 417-421.
Crossref
Kathrin Bauer, Michaela Rancea, Verena Roloff, Thomas Elter, Michael Hallek, Andreas Engert & Nicole Skoetz. (2012) Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia. Cochrane Database of Systematic Reviews.
Crossref
Lukáš Smolej, Michael Doubek, Anna Panovská, Martin Šimkovič, Yvona Brychtová, David Belada, Monika Motyčková & Jiří Mayer. (2012) Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia. Leukemia Research 36:10, pages 1278-1282.
Crossref
Andrew R. PettittRichard JacksonStacey CarruthersJames DoddSusanna DoddMelanie OatesGillian G. JohnsonAnna SchuhEstella MatutesClaire E. DeardenDaniel CatovskyJohn A. RadfordAdrian BloorGeorge A. FollowsStephen DevereuxAnton KrugerJulie BlundellSamir AgrawalDavid AllsupStephen ProctorEarnest HeartinDavid OscierTerry J. HamblinAndrew RawstronPeter Hillmen. (2012) Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53 : Final Results of the National Cancer Research Institute CLL206 Trial . Journal of Clinical Oncology 30:14, pages 1647-1655.
Crossref
Karen W. L. Yee & Susan M. O'Brien. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 81 102 .
Lukáš Smolej. (2010) How I Treat Elderly or Comorbid Patients with Chronic Lymphocytic Leukemia. Acta Medica (Hradec Kralove, Czech Republic) 53:4, pages 213-220.
Crossref
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.